NCT03098472View on ClinicalTrials.gov

Cholinesterase Activity and DeliriUm During Critical Illness Study

CompletedOBSERVATIONAL
Enrollment

279

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

January 1, 2020

Study Completion Date

February 1, 2021

Conditions
DeliriumCognitive Impairment
Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

DR. FRANZ KOHLER CHEMIE GMBH

UNKNOWN

lead

Vanderbilt University Medical Center

OTHER

NCT03098472 - Cholinesterase Activity and DeliriUm During Critical Illness Study | Biotech Hunter | Biotech Hunter